{"paper_id": "493de1ec7f00c7eca8a6aed32c2dd98bf190256e", "metadata": {"title": "A candidate multi-epitope vaccine against SARS-CoV-2", "authors": [{"first": "Tamalika", "middle": [], "last": "Kar", "suffix": "", "affiliation": {"laboratory": "", "institution": "Garden City University Bangalore", "location": {"region": "Karnataka", "country": "India"}}, "email": ""}, {"first": "Utkarsh", "middle": [], "last": "Narsaria", "suffix": "", "affiliation": {"laboratory": "", "institution": "Garden City University Bangalore", "location": {"region": "Karnataka", "country": "India"}}, "email": ""}, {"first": "Srijita", "middle": [], "last": "Basak", "suffix": "", "affiliation": {"laboratory": "", "institution": "Garden City University Bangalore", "location": {"region": "Karnataka", "country": "India"}}, "email": ""}, {"first": "Debashrito", "middle": [], "last": "Deb", "suffix": "", "affiliation": {"laboratory": "", "institution": "Garden City University Bangalore", "location": {"region": "Karnataka", "country": "India"}}, "email": ""}, {"first": "Filippo", "middle": [], "last": "Castiglione", "suffix": "", "affiliation": {"laboratory": "", "institution": "Institute for Applied Computing National Research Council of Italy Via dei Taurini", "location": {"settlement": "Rome", "country": "Italy"}}, "email": ""}, {"first": "David", "middle": ["M"], "last": "Mueller", "suffix": "", "affiliation": {"laboratory": "", "institution": "The Chicago Medical School Rosalind Franklin University of Medicine and Science North Chicago", "location": {"country": "USA"}}, "email": ""}, {"first": "Anurag", "middle": ["P"], "last": "Srivastava", "suffix": "", "affiliation": {"laboratory": "", "institution": "Garden City University Bangalore", "location": {"region": "Karnataka", "country": "India"}}, "email": ":anurag.srivastava@gardencity.university"}]}, "abstract": [], "body_text": [{"text": "The N-terminal of the sequence considered is M (Met).", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). >20 hours (yeast, in vivo). >10 hours (Escherichia coli, in vivo).", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "The instability index (II) is computed to be 31.04 This classifies the protein as stable. ", "cite_spans": [], "ref_spans": [], "section": "Instability index:"}], "bib_entries": {"BIBREF5": {"ref_id": "b5", "title": "CA PHE 19 A <--> 15698 CB PRO 134 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "CD1 PHE 19 A <--> 15698 CB PRO 134 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "CD1 PHE 19 A <--> 15699 CG PRO 134 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "189 OH TYR 20 A <--> 15537 CD2 LEU 114 B 3.40 15. 197 CG LYS 21 A <--> 15465 CB ALA 106 B 3.76 16. 198 CD LYS 21 A <", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "CB ASN 25 A <--> 15730 OH TYR 138 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "OD1 ASN 25 A <--> 15729 CZ TYR 138 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF13": {"ref_id": "b13", "title": "NH1 ARG 41 A <--> 15487 NZ LYS 109 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "394 NH1 ARG 41 A <--> 15528 OD2 ASP 113 B 3.59 42. 397 NH2 ARG 41 A <--> 15526 CG ASP 113 B 3.36 43", "authors": [], "year": null, "venue": "", "volume": "397", "issn": "", "pages": "", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "OD2 ASP 516 A <--> 6190 NZ LYS 85 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "OD2 ASP 520 A <--> 6159 NZ LYS 82 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "OD2 ASP 536 A <--> 6648 OH TYR 138 B", "authors": [], "year": null, "venue": "", "volume": "2", "issn": "", "pages": "", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "NE ARG 541 A <--> 6326 O ALA 99 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF21": {"ref_id": "b21", "title": "5021 NH2 ARG 541 A <--> 6326 O ALA 99 B 2.99 6. 5041 OD2 ASP 543 A <--> 6415 OG SER 110 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "O CYS 574 A <--> 6405 NZ LYS 109 B", "authors": [], "year": null, "venue": "", "volume": "2", "issn": "", "pages": "", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "O PRO 575 A <--> 6440 N ASP 113 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "O PRO 575 A <--> 6449 N LEU 114 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF26": {"ref_id": "b26", "title": "CG2 THR 491 A <--> 6293 ND1 HIS 95 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF35": {"ref_id": "b35", "title": "CG ASP 516 A <--> 6189 CE LYS 85 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF36": {"ref_id": "b36", "title": "CG ASP 516 A <--> 6190 NZ LYS 85 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF37": {"ref_id": "b37", "title": "4766 OD1 ASP 516 A <--> 6343 O SER 101 B 3.41 19. 4766 OD1 ASP 516 A <", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF38": {"ref_id": "b38", "title": "OD2 ASP 536 A <--> 6647 CZ TYR 138 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF40": {"ref_id": "b40", "title": "CA CYS 539 A <--> 6415 OG SER 110 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF45": {"ref_id": "b45", "title": "5008 O PRO 540 A <--> 6355 CA ALA 103 B 3.25 51. 5008 O PRO 540 A <--> 6356 CB ALA 103 B 3.60 52. 5004 CB", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF47": {"ref_id": "b47", "title": "O ARG 541 A <--> 6352 O MET 102 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF50": {"ref_id": "b50", "title": "54 67. 5013 CG ARG 541 A <--> 6350 CE MET 102 B 3.77 68. 5015 NE ARG 541 A <", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF51": {"ref_id": "b51", "title": "5038 CB ASP 543 A <--> 6383 CB ALA 106 B 3.64 79. 5039 CG ASP 543 A <", "authors": [], "year": null, "venue": "", "volume": "6385", "issn": "", "pages": "", "other_ids": {}}, "BIBREF52": {"ref_id": "b52", "title": "OD2 ASP 543 A <--> 6402 CG LYS 109 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF53": {"ref_id": "b53", "title": "5041 OD2 ASP 543 A <--> 6414 CB SER 110 B 3.49 89. 5041 OD2 ASP 543 A <--> 6415 OG", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF56": {"ref_id": "b56", "title": "76 102. 5355 C PRO 575 A <--> 6443 CB ASP 113 B 3.59 103. 5355 C PRO 575 A <--> 6449 N LEU 114 B 3.31 104. 5355 C PRO 575 A <--> 6451 CA LEU 114 B 3.90 105. 5355 C PRO 575 A <--> 6452 CB LEU 114 B 3.66 106. 5355 C PRO 575 A <--> 6455 CD2 LEU 114 B 3.84 107. 5356 O PRO 575 A <--> 6410 O LYS 109 B 3.28 108. 5356 O PRO 575 A <--> 6413 CA", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF57": {"ref_id": "b57", "title": "O PRO 575 A <--> 6418 O SER 110 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF58": {"ref_id": "b58", "title": "5356 O PRO 575 A <--> 6447 C ASP 113 B 3.37 114. 5356 O PRO 575 A <--> 6443 CB ASP 113 B 3.11 115. 5356 O PRO 575 A <--> 6449 N LEU 114 B 2.93 116. 5356 O PRO 575 A <--> 6451 CA LEU 114 B 3.89 117. 5356 O PRO 575 A <--> 6452 CB LEU 114 B 3.81 118. 5352 CB PRO 575 A <--> 6455 CD2 LEU 114 B 3.59 119. 5353 CG PRO 575 A <--> 6605 OH", "authors": [{"first": "O", "middle": [], "last": "Pro", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF59": {"ref_id": "b59", "title": "NH2 ARG 17 A <--> 4624 O PHE 202 B", "authors": [], "year": null, "venue": "", "volume": "2", "issn": "", "pages": "", "other_ids": {}}, "BIBREF60": {"ref_id": "b60", "title": "NH2 ARG 17 A <--> 4629 O GLY 203 B 2.71 5. 182 N GLU 19 A <--> 3932 O PRO 122 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF61": {"ref_id": "b61", "title": "NH2 ARG 35 A <--> 3857 OD2 ASP 113 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF68": {"ref_id": "b68", "title": "60 23. 140 NH1 ARG 14 A <--> 3937 O GLY 123 B 2.79 24. 140 NH1 ARG 14 A <--> 3958 OG1", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF72": {"ref_id": "b72", "title": "166 NE ARG 17 A <--> 4569 CZ2 TRP 197 B 3.65 34. 166 NE ARG 17 A <", "authors": [{"first": "O", "middle": [], "last": "Arg", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF73": {"ref_id": "b73", "title": "CA GLY 18 A <--> 3932 O PRO 122 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF74": {"ref_id": "b74", "title": "CA GLU 19 A <--> 3932 O PRO 122 B 3.88 45. 207 CZ ARG 21 A <", "authors": [{"first": "C", "middle": [], "last": "Gly", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF75": {"ref_id": "b75", "title": "CD1 ILE 23 A <--> 4011 CD1 TYR 132 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF76": {"ref_id": "b76", "title": "391 O ASP 39 A <--> 3887 CD2 LEU 116 B 3.22 79. 391 O ASP 39 A <", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF81": {"ref_id": "b81", "title": "86 97. 1213 O ASP 119 A <--> 4519 O GLY 191 B 3.14 98. 1213 O ASP 119 A <--> 4521 CA", "authors": [], "year": null, "venue": "OG SER 92 A <--> 4563 CD1 TRP 197 B 3.17 96. 1212 C ASP 119 A <--> 4519 O GLY 191 B 3", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF82": {"ref_id": "b82", "title": "CA GLY 120 A <--> 4521 CA PRO 192 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF87": {"ref_id": "b87", "title": "CE1 HIS 188 A <--> 3704 ND1 HIS 95 B 3.81 112. 1908 CE1 HIS 188 A <--> 3705 CD2 HIS 95 B 3.72 113. 1909 NE2 HIS 188 A <--> 3702 CB HIS 95 B 3.80 114. 1909 NE2 HIS 188 A <--> 3703 CG HIS 95 B 3.62 115. 1909 NE2 HIS 188 A <", "authors": [], "year": 1908, "venue": "CE1 HIS 188 A <--> 3703 CG HIS 95 B 3.59 111", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF88": {"ref_id": "b88", "title": "CB HIS 192 A <--> 3664 OD1 ASN 91 B 3.21 120. 1947 CG HIS 192 A <--> 3664 OD1 ASN 91 B 3.48 121. 1948 ND1 HIS 192 A <--> 3682 O LYS 92 B 3.84 122. 1949 CD2 HIS 192 A <--> 3661 CA ASN 91 B 3.58 123. 1949 CD2 HIS 192 A <", "authors": [], "year": 1946, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF89": {"ref_id": "b89", "title": "NE2 HIS 192 A <--> 3628 CG1 VAL 88 B 3.68 130", "authors": [], "year": 1951, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF92": {"ref_id": "b92", "title": "CA VAL 194 A <--> 3665 ND2 ASN 91 B 3.83 136. 2035 CB ARG 202 A <--> 3687 OG1 THR 93 B 3.69 137. 2036 CG ARG 202 A <--> 3687 OG1", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF93": {"ref_id": "b93", "title": "2083 CD1 LEU 206 A <--> 3704 ND1 HIS 95 B 3.81 154. 2083 CD1 LEU 206 A <--> 3706 CE1 HIS 95 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF97": {"ref_id": "b97", "title": "2432 NE2 GLN 242 A <--> 3761 CE MET 102 B 3.55 Salt bridges", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF99": {"ref_id": "b99", "title": "Number of salt bridges: 1 Number of hydrogen bonds: 13 Number of non-bonded contacts", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF100": {"ref_id": "b100", "title": "Vaccine-MHC II PDBsum interacting molecules Hydrogen bonds", "authors": [], "year": null, "venue": "", "volume": "5", "issn": "", "pages": "", "other_ids": {}}, "BIBREF102": {"ref_id": "b102", "title": "OE2 GLU 1 A <--> 4922 N GLY 133 B 2.69 2. 833 OE2 GLU 86 A <--> 4503 NZ LYS 85 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF109": {"ref_id": "b109", "title": "A <--> 5414 CD PRO 190 B 3", "authors": [{"first": "O", "middle": [], "last": "Glu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF110": {"ref_id": "b110", "title": "CB GLU 1 A <--> 4926 O GLY 133 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF111": {"ref_id": "b111", "title": "CG GLU 1 A <--> 4907 O TYR 131 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF112": {"ref_id": "b112", "title": "CG GLU 1 A <--> 4926 O GLY 133 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF113": {"ref_id": "b113", "title": "CD GLU 1 A <--> 4922 N GLY 133 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF114": {"ref_id": "b114", "title": "CD GLU 1 A <--> 4926 O GLY 133 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF115": {"ref_id": "b115", "title": "OE2 GLU 1 A <--> 4920 C TYR 132 B 3", "authors": [], "year": null, "venue": "", "volume": "43", "issn": "", "pages": "", "other_ids": {}}, "BIBREF116": {"ref_id": "b116", "title": "OE2 GLU 1 A <--> 4922 N GLY 133 B 2", "authors": [], "year": null, "venue": "", "volume": "69", "issn": "", "pages": "", "other_ids": {}}, "BIBREF117": {"ref_id": "b117", "title": "OE2 GLU 1 A <--> 4924 CA GLY 133 B 3", "authors": [], "year": null, "venue": "", "volume": "72", "issn": "", "pages": "", "other_ids": {}}, "BIBREF118": {"ref_id": "b118", "title": "OE2 GLU 1 A <--> 4925 C GLY 133 B 3", "authors": [], "year": null, "venue": "", "volume": "66", "issn": "", "pages": "", "other_ids": {}}, "BIBREF119": {"ref_id": "b119", "title": "OE2 GLU 1 A <--> 4926 O GLY 133 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF124": {"ref_id": "b124", "title": "4943 CD PRO 136 B 3.30 21. 36 CB VAL 4 A <--> 4928 CA PRO", "authors": [{"first": "O", "middle": [], "last": "Glu 2 A &lt;--&gt;", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF125": {"ref_id": "b125", "title": "28. 242 CG ASP 25 A <--> 4943 CD PRO 136 B 3.63 29. 243 OD1 ASP 25 A <--> 4934 N GLY 135 B 3.73 30. 243 OD1 ASP 25 A <", "authors": [{"first": "O", "middle": [], "last": "Asp", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF126": {"ref_id": "b126", "title": "OE2 GLU 86 A <--> 4503 NZ LYS 85 B 2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF130": {"ref_id": "b130", "title": "CD1 LEU 90 A <--> 4607 CD2 HIS 95 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF131": {"ref_id": "b131", "title": "B 3.26 49. 1046 CE LYS 109 A <--> 4662 SD MET 102 B 3.38 50", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF132": {"ref_id": "b132", "title": "68. 1347 O ASP 140 A <--> 4759 OD2 ASP 113 B 3.88 69", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF133": {"ref_id": "b133", "title": "1649 OD1 ASP 169 A <--> 4393 CZ ARG 74 B 3.72 89", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF134": {"ref_id": "b134", "title": "2172 CZ ARG 217 A <--> 4789 CD2 LEU 116 B 3.80 103. 2173 NH1 ARG 217 A <--> 4782 O PHE 115 B 3.84 104. 2176 NH2 ARG 217 A <--> 4782 O PHE 115 B 2.87 105. 2176 NH2 ARG 217 A <--> 4789 CD2 LEU 116 B 3.84 106", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF137": {"ref_id": "b137", "title": "O ILE 305 A <--> 5195 CG PRO 164 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF139": {"ref_id": "b139", "title": "CG2 THR 323 A <--> 4615 CA ALA 96 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF140": {"ref_id": "b140", "title": "CG2 THR 323 A <--> 4618 O ALA 96 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF141": {"ref_id": "b141", "title": "CG2 THR 323 A <--> 4637 CB ALA 99 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF142": {"ref_id": "b142", "title": "CA GLY 324 A <--> 5186 O PRO 162 B 3", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF144": {"ref_id": "b144", "title": "CE MET 338 A <--> 4589 OG1 THR 93 B", "authors": [], "year": null, "venue": "", "volume": "3", "issn": "", "pages": "", "other_ids": {}}, "BIBREF147": {"ref_id": "b147", "title": "Number of salt bridges: 3 Number of hydrogen bonds: 17 Number of non-bonded contacts", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Phylogenetic analysis of spike glycoprotein of SARS-CoV-2, isolated from 19 different countries (China, Japan, USA, Australia, Finland, Sweden, India, Colombia, Taiwan, Pakistan, Italy, Israel, Iran, Iran, Vietnam, Peru, Brazil, Spain, Nepal, South Korea) around the globe indicating very low diversity. Supplementary Signal Continuous Epitopes predicted by ElliPro and visualized using PyMol. Epitopes are shown in blue colour and the vaccine is shown in hot pink colour B. Discontinuous Epitopes predicted by ElliPro and visualized using PyMol. Epitopes are shown in green colour and the vaccine is shown in red colour. The results and graphics presented below are based on HADDOCK generated water-refined models of TLR 4 with vaccine construct. i-RMSD -> interface-RMSD calculated on the backbone (CA,C,N,O,P) atoms of all residues involved in intermolecular contact using a 10\u00c5 cutoff. l-RMSD -> ligand-RMSD calculated on the backbone atoms (CA,C,N,O,P) of all (N>1) molecules after fitting on the backbone atoms of the first (N=1) molecule. FCC -> Fraction of common contacts. The intermolecular contacts are defined based on the best HADDOCK model using a 5\u00c5 cutoff. a.u. -> Arbitrary Units. The cluster averages and standard deviations are indicated by colored dots with associated error bars. The average values are calculated on the best 4 structures of each clusters (based on the HADDOCK score). Supplementary Figure S8: Overview of docked complex TLR4 and vaccine. Hydrogen bonds are shown with black dashes and orange dashes indicate the salt bridges. Supplementary Figure S9: Ramachandran plot analysis of vaccine-TLR2 docked complex. The results and graphics presented below are based on HADDOCK generated water-refined models of TLR2 with vaccine construct. i-RMSD -> interface-RMSD calculated on the backbone (CA,C,N,O,P) atoms of all residues involved in intermolecular contact using a 10\u00c5 cutoff. l-RMSD -> ligand-RMSD calculated on the backbone atoms (CA,C,N,O,P) of all (N>1) molecules after fitting on the backbone atoms of the first (N=1) molecule. FCC -> Fraction of common contacts. The intermolecular contacts are defined based on the best HADDOCK model using a 5\u00c5 cutoff. a.u. -> Arbitrary Units. The cluster averages and standard deviations are indicated by colored dots with associated error bars. The average values are calculated on the best 4 structures of each clusters (based on the HADDOCK score). Supplementary Figure S11: Overview of docked complex TLR2 and vaccine. Hydrogen bonds are shown with black dashes and green dashes indicate salt bridges. Supplementary Figure S12: Ramachandran plot analysis of vaccine-MHC Class I receptor docked complex. The results and graphics presented below are based on HADDOCK generated water-refined models of docked vaccine MHC Class I receptor. Supplementary Figure S14: Overview of docked vaccine MHC Class I receptor complex. Hydrogen bonds are shown with black dashes and yellow dashes indicate salt bridges. Supplementary Figure S15: Ramachandran plot analysis of vaccine-MHC II docked complex. The results and graphics presented below are based on HADDOCK generated water-refined models of docked vaccine MHC Class II receptor. Supplementary Figure S17: Overview of docked vaccine MHC Class II receptor complex. Hydrogen bonds are shown with black dashes and pink dashes indicate salt bridges. Supplementary Figure S18: Plots showing detailed dynamics of immune simulation variables. Plots of immune simulation variables in the control case corresponding to a \"Live virus\" which infects the host at day 365 without previous vaccination.", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Aliphatic index: 78.74 Grand average of hydropathicity (GRAVY): -0.088 Supplementary material SM 2: Vaccine-TLR 4/MD2 PDBsum interacting molecules Hydrogen bonds <-----A T O M 1 -----> <-----A T O M 2 -----> Atom Atom Res Res Atom Atom Res Res no. name name no. Chain no. name name no. Chain Distance 1. 200 NZ LYS 21 A <--> 15749 OE1 GLN 140 B 2<-----A T O M 1 -----> <-----A T O M 2 -----> Atom Atom Res Res Atom Atom Res Res no. name name no. Chain no. name name no. Chain Distance 1.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Salt bridges <-----A T O M 1 -----> <-----A T O M 2 -----> Atom Atom Res Res Atom Atom Res Res no. name name no. Chain no. name name no. Chain Distance 1. 397 NH2 ARG 41 A <--> 15528 OD2 ASP 113 B 2no. name name no. Chain no. name name no. Chain Distance", "latex": null, "type": "figure"}, "TABREF1": {"text": "Supplementary material SM 1: Physico-chemical property of the candidate vaccine Number of amino acids: 422 Molecular weight: 44153.58 Theoretical pI: 9.96 Total number of negatively charged residues (Asp + Glu): 19 Total number of positively charged residues (Arg + Lys): 33 Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. Ext. coefficient 49515 Abs 0.1% (=1 g/l) 1.121, assuming all pairs of Cys residues form cystines Ext. coefficient 49390 Abs 0.1% (=1 g/l) 1.119, assuming all Cys residues are reduced Estimated half-life:", "latex": null, "type": "table"}, "TABREF2": {"text": "1 N GLU 1 A <--> 15711 CG PRO 136 B 3.57 52. 435 O SER 45 A <--> 15400 CB ALA 98 B 3.31 53. 431 CB SER 45 A <--> 15270 CD LYS 85 B 3.69 54. 432 OG SER 45 A <--> 15270 CD LYS 85 B 3.89 55. 439 CB TYR 46 A <--> 15400 CB ALA 98 B 3.60 56. 441 CD1 TYR 46 A <--> 15376 CD2 HIS 95 B 3.45 57. 442 CD2 TYR 46 A <--> 15400 CB ALA 98 B 3.77 58. 443 CE1 TYR 46 A <--> 15376 CD2 HIS 95 B 3.77 59. 443 CE1 TYR 46 A <--> 15378 NE2 HIS 95 B 3.81 60. 446 OH TYR 46 A <--> 15284 CD2 LEU 86 B 3.79 61. 452 CA SER 47 A <--> 15432 CE MET 102 B 3.61 62. 453 CB SER 47 A <--> 15432 CE MET 102 B 3.87 63. 473 CB PHE 49 A <--> 15381 O HIS 95 B 3.70 64. 473 CB PHE 49 A <--> 15373 CB HIS 95 B 3.44 65. 474 CG PHE 49 A <--> 15380 C HIS 95 B 3.65 66. 474 CG PHE 49 A <--> 15381 O HIS 95 B 3.31 67. 474 CG PHE 49 A <--> 15373 CB HIS 95 B 3.82 68. 475 CD1 PHE 49 A <--> 15381 O HIS 95 B 3.23 69. 476 CD2 PHE 49 A <--> 15380 C HIS 95 B 3.83 70. 476 CD2 PHE 49 A <--> 15381 O HIS 95 B 3.87 71. 476 CD2 PHE 49 A <--> 15373 CB HIS 95 B 3.83 72. 476 CD2 PHE 49 A <--> 15382 N ALA 96 B 3.90 73. 477 CE1 PHE 49 A <--> 15381 O HIS 95 B 3.74 74. 477 CE1 PHE 49 A <--> 15384 CA ALA 96 B 3.89 75. 477 CE1 PHE 49 A <--> 15406 CB ALA 99 B 3.60 76. 478 CE2 PHE 49 A <--> 15384 CA ALA 96 B 3.63 77. 478 CE2 PHE 49 A <--> 15385 CB ALA 96 B 3.77 78. 479 CZ PHE 49 A <--> 15384 CA ALA 96 B 3.55 79. 479 CZ PHE 49 A <--> 15385 CB ALA 96 B 3.86 80. 645 CG2 THR 66 A <--> 15206 CD2 LEU 78 B 3.67 81. 662 CD GLU 68 A <--> 15238 CG LYS 82 B 3.89 82. 662 CD GLU 68 A <--> 15272 NZ LYS 85 B 3.21 83. 663 OE1 GLU 68 A <--> 15238 CG LYS 82 B 3.61 84. 663 OE1 GLU 68 A <--> 15270 CD LYS 85 B 3.60 85. 663 OE1 GLU 68 A <--> 15271 CE LYS 85 B 3.20 86. 663 OE1 GLU 68 A <--> 15272 NZ LYS 85 B 2.60 87. 664 OE2 GLU 68 A <--> 15231 CB ALA 81 B 3.68 88. 664 OE2 GLU 68 A <--> 15272 NZ LYS 85 B 3.06 89. 671 CG ASP 69 A <--> 15241 NZ LYS 82 B 3.59 90. 672 OD1 ASP 69 A <--> 15240 CE LYS 82 B 3.40 91. 672 OD1 ASP 69 A <--> 15241 NZ LYS 82 B 2.67 92. 717 OG SER 74 A <--> 15376 CD2 HIS 95 B 3.46 93. 859 CB SER 90 A <--> 15160 NE ARG 74 B 3.89 94. 860 OG SER 90 A <--> 15159 CD ARG 74 B 3.29 95. 860 OG SER 90 A <--> 15160 NE ARG 74 B 3.43", "latex": null, "type": "table"}, "TABREF3": {"text": "Table 1: All the CTL epitopes as predicted by NetCTL 1.2", "latex": null, "type": "table", "html": "<html><body><table><tr><td>MHC Super type </td><td>EPITOPES </td><td>CTL Epitope prediction POSITION </td><td>by NetCTL-1.2 Server PREDICTION SCORE </td><td>IMMUNOGENIC SCORE </td><td>ANTIGENICITY SCORE </td></tr><tr><td>LTDEMIAQY </td><td>865 </td><td>3.6616 </td><td>0.02757 </td><td>0.1043 </td></tr><tr><td>\u00a0</td><td>WTAGAAAYY </td><td>258 </td><td>3.1128 </td><td>0.15259 </td><td>0.6306 </td></tr><tr><td>\u00a0</td><td>TSNQVAVLY </td><td>604 </td><td>3.0758 </td><td>-0.01327 </td><td>0.4387 </td></tr><tr><td>\u00a0</td><td>CVADYSVLY </td><td>361 </td><td>2.5759 </td><td>-0.09595 </td><td>-0.0293 </td></tr><tr><td>\u00a0</td><td>KTSVDCTMY </td><td>733 </td><td>2.3795 </td><td>-0.11115 </td><td>1.1824 </td></tr><tr><td>\u00a0</td><td>STECSNLLL </td><td>746 </td><td>2.3492 </td><td>-0.20478 </td><td>0.4871 </td></tr><tr><td>\u00a0</td><td>GAEHVNNSY </td><td>652 </td><td>1.9960 </td><td>-0.00296 </td><td>0.9347 </td></tr><tr><td>\u00a0</td><td>NIDGYFKIY </td><td>196 </td><td>1.9606 </td><td>0.04366 </td><td>-0.2462 </td></tr><tr><td>\u00a0</td><td>YSSANNCTF </td><td>160 </td><td>1.9531 </td><td>-0.04954 </td><td>-0.1036 </td></tr><tr><td>\u00a0</td><td>WMESEFRVY </td><td>152 </td><td>1.9232 </td><td>0.14153 </td><td>0.2698 </td></tr><tr><td>\u00a0</td><td>SANNCTFEY </td><td>162 </td><td>1.8739 </td><td>0.13273 </td><td>-0.0924 </td></tr><tr><td>\u00a0</td><td>VASQSIIAY </td><td>687 </td><td>1.7978 </td><td>-0.0709 </td><td>0.1366 </td></tr><tr><td>\u00a0</td><td>NSFTRGVYY </td><td>30 </td><td>1.6915 </td><td>0.19204 </td><td>-0.1877 </td></tr><tr><td>\u00a0</td><td>CNDPFLGVY </td><td>136 </td><td>1.3355 </td><td>0.15232 </td><td>0.4295 </td></tr><tr><td>\u00a0</td><td>FTNVYADSF </td><td>392 </td><td>1.3208 </td><td>-0.00527 </td><td>-0.5651 </td></tr><tr><td>\u00a0</td><td>GAAAYYVGY </td><td>261 </td><td>1.2194 </td><td>0.09963 </td><td>0.6604 </td></tr><tr><td>MHC supertype </td><td>RISNCVADY </td><td>357 </td><td>1.2032 </td><td>-0.02787 </td><td>-0.5375 </td></tr><tr><td>ERDISTEIY </td><td>465 </td><td>1.1687 </td><td>0.17882 </td><td>-0.2317 </td></tr><tr><td>A1. Threshold 0.750000 </td><td>ITDAVDCAL </td><td>285 </td><td>1.1680 </td><td>0.08501 </td><td>0.5260 </td></tr><tr><td>RVDFCGKGY </td><td>1039 </td><td>1.1403 </td><td>-0.0578 </td><td>0.3717 </td></tr><tr><td>\u00a0</td><td>NATRFASVY </td><td>343 </td><td>1.1138 </td><td>0.10001 </td><td>-0.0081 </td></tr><tr><td>\u00a0</td><td>STQDLFLPF </td><td>50 </td><td>1.0468 </td><td>0.06828 </td><td>0.6619 </td></tr><tr><td>\u00a0</td><td>VSNGTHWFV </td><td>1096 </td><td>0.9574 </td><td>0.35559 </td><td>-0.1239 </td></tr><tr><td>\u00a0</td><td>GTITSGWTF </td><td>880 </td><td>0.9433 </td><td>0.16268 </td><td>0.3272 </td></tr><tr><td>\u00a0</td><td>RSFIEDLLF </td><td>815 </td><td>0.8441 </td><td>0.27446 </td><td>-0.5782 </td></tr><tr><td>\u00a0</td><td>HSAWSHPQF </td><td>1257 </td><td>0.8279 </td><td>0.0279 </td><td>0.8569 </td></tr><tr><td>\u00a0</td><td>ECSNLLLQY </td><td>748 </td><td>0.8171 </td><td>-0.15849 </td><td>0.3331 </td></tr><tr><td>\u00a0</td><td>NSASFSTFK </td><td>370 </td><td>0.8165 </td><td>-0.09434 </td><td>0.1232 </td></tr><tr><td>\u00a0</td><td>ASFSTFKCY </td><td>372 </td><td>0.8085 </td><td>-0.19397 </td><td>0.2795 </td></tr><tr><td>\u00a0</td><td>QLTPTWRVY </td><td>628 </td><td>0.7887 </td><td>0.31555 </td><td>1.2119 </td></tr><tr><td>\u00a0</td><td>LSETKCTLK </td><td>296 </td><td>0.7879 </td><td>-0.16291 </td><td>0.6883 </td></tr><tr><td>\u00a0</td><td>FVFKNIDGY </td><td>192 </td><td>0.7837 </td><td>-0.0215 </td><td>-0.1304 </td></tr><tr><td>\u00a0</td><td>VGGNYNYLY </td><td>445 </td><td>0.7698 </td><td>-0.0148 </td><td>0.7432 </td></tr><tr><td>\u00a0</td><td>VLPFNDGVY </td><td>83 </td><td>0.7675 </td><td>0.1815 </td><td>0.4642 </td></tr><tr><td>\u00a0</td><td>FVSNGTHWF </td><td>1095 </td><td>0.7622 </td><td>0.16605 </td><td>0.0807 </td></tr><tr><td>\u00a0</td><td>YQDVNCTEV </td><td>612 </td><td>0.7502 </td><td>0.08295 </td><td>1.6172 </td></tr><tr><td>\u00a0</td><td>YLQPRTFLL </td><td>269 </td><td>1.5152 </td><td>0.1305 </td><td>0.4532 </td></tr><tr><td>\u00a0</td><td>KIADYNYKL </td><td>417 </td><td>1.4347 </td><td>-0.10379 </td><td>1.6639 </td></tr><tr><td>\u00a0</td><td>SIIAYTMSL </td><td>691 </td><td>1.3658 </td><td>-0.12935 </td><td>0.5234 </td></tr><tr><td>\u00a0</td><td>VLNDILSRL </td><td>976 </td><td>1.3540 </td><td>0.03 </td><td>-0.8524 </td></tr><tr><td>MHC supertype A2. Threshold </td><td>RLQSLQTYV </td><td>1000 </td><td>1.2727 </td><td>-0.29331 </td><td>-0.2167 </td></tr><tr><td>FVFLVLLPL </td><td>2 </td><td>1.1947 </td><td>0.04076 </td><td>0.8601 </td></tr><tr><td>0.750000 </td><td>FTISVTTEI </td><td>718 </td><td>1.1808 </td><td>0.04473 </td><td>0.8535 </td></tr><tr><td>\u00a0</td><td>MIAQYTSAL </td><td>869 </td><td>1.1735 </td><td>-0.18768 </td><td>0.1114 </td></tr><tr><td>\u00a0</td><td>FQFCNDPFL </td><td>133 </td><td>1.1416 </td><td>0.05737 </td><td>-0.2493 </td></tr><tr><td>\u00a0</td><td>FLGRSLEVL </td><td>1236 </td><td>1.1019 </td><td>0.00016 </td><td>0.6113 </td></tr><tr><td>\u00a0</td><td>TLDSKTQSL </td><td>109 </td><td>1.0777 </td><td>-0.52715 </td><td>1.0685 </td></tr></table></body></html>"}, "TABREF4": {"text": "Table 2: All the HTL epitopes as predicted by NetMHC II pan 3.2", "latex": null, "type": "table", "html": "<html><body><table><tr><td>EPITOPES (POSITION) </td><td>CORE SEQUENCE </td><td>HLA ALLELES II </td><td>SCORE </td><td>IMMUNOGE\nNICITY </td><td>ANTIGENICIT\nY </td></tr><tr><td>VLSFELLHAPATVCG (512) </td><td>FELLHAPAT </td><td>DRB1*01:01 </td><td>0.30 </td><td>0.27678 </td><td>0.4784 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:01 </td><td>0.60 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:05 </td><td>1.00 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>IIAYTMSLGAENSVA </td><td>\u00a0</td><td>DRB1*07:01 </td><td>2.00 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>(692) </td><td>YTMSLGAEN </td><td>DRB1*09:01 </td><td>0.20 </td><td>-0.24911 </td><td>0.5426 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DQA1*04:01-DQB1*04:02 </td><td>1.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DQA1*01:02-DQB1*06:02 </td><td>2.00 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*14:01 </td><td>1.90 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>VVLSFELLHAPATVC (511) </td><td>FELLHAPAT </td><td>DRB1*01:01 </td><td>0.40 </td><td>0.17234 </td><td>0.8618 </td></tr><tr><td>VVVLSFELLHAPATV (510) </td><td>FELLHAPAT </td><td>DRB1*01:01 </td><td>0.40 </td><td>0.1459 </td><td>0.8083 </td></tr><tr><td>LSFELLHAPATVCGP (513) </td><td>FELLHAPAT </td><td>DRB1*01:01 </td><td>0.40 </td><td>0.26501 </td><td>0.5062 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.50 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:05 </td><td>1.00 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>SIIAYTMSLGAENSV </td><td>YTMSLGAEN </td><td>DRB1*07:01 </td><td>1.60 </td><td>-0.1629 </td><td>0.5691 </td></tr><tr><td>(691) </td><td>\u00a0</td><td>DRB1*09:01 </td><td>0.20 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DQA1*04:01-DQB1*04:02 </td><td>1.80 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*14:01 </td><td>1.90 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:01 </td><td>1.50 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:05 </td><td>0.60 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*08:02 </td><td>1.60 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*11:01 </td><td>0.30 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>TRFQTLLALHRSYLT </td><td>FQTLLALHR </td><td>DRB1*12:01 </td><td>0.40 </td><td>-0.11849 </td><td>0.3262 </td></tr><tr><td>(236) </td><td>\u00a0</td><td>DRB1*15:01 </td><td>0.30 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB4*01:01 </td><td>1.20 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*05:01 </td><td>0.60 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*14:01 </td><td>0.90 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB5*01:01 </td><td>0.09 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:01 </td><td>1.10 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*04:05 </td><td>0.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*08:02 </td><td>1.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*11:01 </td><td>0.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>ITRFQTLLALHRSYL </td><td>FQTLLALHR </td><td>DRB1*12:01 </td><td>0.30 </td><td>0.00374 </td><td>0.1131 </td></tr><tr><td>(235) </td><td>\u00a0</td><td>DRB1*15:01 </td><td>0.50 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB4*01:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*05:01 </td><td>0.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DPA1*02:01-DPB1*14:01 </td><td>0.50 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB5*01:01 </td><td>0.08 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>IAYTMSLGAENSVAY </td><td>\u00a0</td><td>DRB1*04:01 </td><td>1.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>(693) </td><td>YTMSLGAEN </td><td>DQA1*04:01-DQB1*04:02 </td><td>2.00 </td><td>-0.24077 </td><td>0.7072 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*09:01 </td><td>0.40 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>DRB1*01:01 </td><td>0.70 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>NITRFQTLLALHRSY </td><td>FQTLLALHR </td><td>DRB1*04:01 </td><td>0.70 </td><td>0.08685 </td><td>0.1775 </td></tr><tr><td>(234) </td><td>\u00a0</td><td>DRB1*04:05 </td><td>0.20 </td><td>\u00a0</td><td>\u00a0</td></tr></table></body></html>"}, "TABREF5": {"text": "Table 3: Overlapping HTL and CTL epitopes", "latex": null, "type": "table", "html": "<html><body><table><tr><td>EPITOPES </td><td>CLASS I SUPERTYPE and ALLELES </td><td>CLASS II ALLELES </td></tr><tr><td>INITRFQTLLALHRS </td><td>B8,B27,B39, HLA-A*30:01, HLA-\nB*08:01, HLA-A*31:01 </td><td>DRB1*01:01, DRB1*04:01, DRB1*04:05, DRB1*08:02, DRB1*11:01, DRB1*12:01, DRB1*15:01, DRB4*01:01, DPA1*02:01-\nDPB1*05:01, DPA1*02:01-DPB1*14:01, DRB5*01:01 </td></tr><tr><td>GINITRFQTLLALHR </td><td>B8,B27,B39 HLA-A*30:01, HLA-\nB*08:01, HLA-A*31:01 </td><td>DRB1*01:01, DRB1*04:01, DRB1*04:05, DRB1*11:01, DRB1*12:01. DRB1*15:01, DRB4*01:01, DRB5*01:01, DPA1*03:01-\nDPB1*04:02, DPA1*02:01-DPB1*05:01, DPA1*02:01-DPB1*14:01, DPA1*02:01-\n</td></tr><tr><td>A26,B62 </td><td>DPB1*01:01 DRB1*01:01, DRB1*09:01, DQA1*03:01-\n</td></tr><tr><td>GWTFGAGAALQIPFA </td><td>HLA-A*68:02, HLA-\nA*26:01, HLA-B*51:01, </td><td>DQB1*03:02, DQA1*04:01-DQB1*04:02, DQA1*01:02-DQB1*06:02, DQA1*05:01-\n</td></tr><tr><td>HLA-A*30:01, HLA-\nB*07:02, HLA-B*15:01, </td><td>DQB1*03:01 </td></tr><tr><td>IRAAEIRASANLAAT </td><td>B7,B44, HLA-B*40:01, HLA-\nB*44:03, HLA-B*44:02, </td><td>DRB1*04:01, DRB1*08:02, DRB1*13:02, DPA1*02:01-DPB1*14:01, DQA1*01:02-\n</td></tr><tr><td>HLA-B*07:02 A3,B7,B44, </td><td>DQB1*06:02, DQA1*05:01-DQB1*03:01 </td></tr><tr><td>AAEIRASANLAATKM </td><td>HLA-B*40:01, HLA-\n</td><td>DRB1*04:01, DRB1*08:02, DRB1*13:01, </td></tr><tr><td>B*44:03, HLA-B*44:02, HLA-A*11:01, HLA-\n</td><td>DPA1*02:01-DPB1*14:01, DQA1*01:02-\n</td></tr><tr><td>A*03:01 </td><td>DQB1*06:02, DRB3*02:02 </td></tr><tr><td>WTFGAGAALQIPFAM </td><td>A26,B7,B58,B62 </td><td>\u00a0</td></tr><tr><td>HLA-B*35:01, HLA-\nA*68:02, HLA-A*26:01, HLA-B*51:01, HLA-\n</td><td>DRB1*09:01, DQA1*03:01-DQB1*03:02, DQA1*04:01-DQB1*04:02, DQA1*01:02-\n</td></tr><tr><td>A*30:01, HLA-B*07:02, HLA-B*15:01 </td><td>DQB1*06:02, DQA1*05:01-DQB1*03:01 </td></tr><tr><td>QPYRVVVLSFELLHA </td><td>A2,A24,B7,B58,B62 </td><td>DPA1*02:01-DPB1*01:01, DPA1*01:03-\n</td></tr><tr><td>HLA-A*23:01, HLA-\nA*24:02, HLA-A*02:03, HLA-A*02:06, HLA-\n</td><td>DPB1*04:01, DPA1*03:01-DPB1*04:02, DPA1*02:01-DPB1*05:01, DPA1*01:03-\n</td></tr><tr><td>A*32:01 A2,A24,B7,B58,B62 </td><td>DPB1*02:01 </td></tr><tr><td>PYRVVVLSFELLHAP </td><td>HLA-A*23:01, HLA-\nA*24:02, HLA-A*02:03, HLA-A*02:06, HLA-\nA*32:01 </td><td>DPA1*02:01-DPB1*01:01, DPA1*01:03-\nDPB1*02:01, DPA1*03:01-DPB1*04:02, DPA1*02:01-DPB1*05:01, DPA1*01:03-\nDPB1*04:01 </td></tr></table></body></html>"}, "TABREF6": {"text": "Table 4: IFN Gamma Epitopes as predicted by IFNepitope Server.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>EPITOPES </td><td>SCORE </td><td>ANTIGENICITY </td></tr><tr><td>TRFASVYAWNRKRIS </td><td>0.73155567 </td><td>0.4963 </td></tr><tr><td>GINITRFQTLLALHR </td><td>0.10772613 </td><td>0.5582 </td></tr><tr><td>INITRFQTLLALHRS </td><td>-0.00071534627 </td><td>0.4118 </td></tr><tr><td>PINLVRDLPQGFSAL </td><td>-0.68072819 </td><td>0.6086 </td></tr><tr><td>INLVRDLPQGFSALE </td><td>-1.1224405 </td><td>0.4441 </td></tr></table></body></html>"}}, "back_matter": [{"text": " ATGACCCCGCAGAACATCACCGACCTGTGCGCTGAATACCACAACACCCAGATC  CACACCCTGAACGACAAAATCTTCTCTTACACCGAATCTCTGGCTGGTAAACGTG  AAATGGCTATCATCACCTTCAAAAACGGTGCTACCTTCCAGGTTGAAGTTCCGGG  TTCTCAGCACATCGACTCTCAGAAAAAAGCTATCGAACGTATGAAAGACACCCT  GCGTATCGCTTACCTGACCGAAGCTAAAGTTGAAAAACTGTGCGTTTGGAACAA  CAAAACCCCGCACGCTATCGCTGCTATCTCTATGGCTAACGAAGCTGCTGCTAAA  TCTACCCAGGACCTGTTCCTGCCGTTCGGTCCGGGTCCGGGTTGGACCGCTGGTG  CTGCTGCTTACTACGGTCCGGGTCCGGGTTACCTGCAGCCGCGTACCTTCCTGCT  GGGTCCGGGTCCGGGTTACCAGCCGTACCGTGTTGTTGTTCTGGGTCCGGGTCCG  GGTTTCACCATCTCTGTTACCACCGAAATCGGTCCGGGTCCGGGTCAGATCATCA  CCACCGACAACACCTTCGGTCCGGGTCCGGGTCACTCTGCTTGGTCTCACCCGCA  GTTCGGTCCGGGTCCGGGTGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCT  CTGCACCGTGGTCCGGGTCCGGGTATCAACATCACCCGTTTCCAGACCCTGCTGG  CTCTGCACCGTTCTGGTCCGGGTCCGGGTCAGCCGTACCGTGTTGTTGTTCTGTCT  TTCGAACTGCTGCACGCTGGTCCGGGTCCGGGTCCGTACCGTGTTGTTGTTCTGTC  TTTCGAACTGCTGCACGCTCCGGGTCCGGGTCCGGGTGGTTGGACCTTCGGTGCT  GGTGCTGCTCTGCAGATCCCGTTCGCTGGTCCGGGTCCGGGTTGGACCTTCGGTG  CTGGTGCTGCTCTGCAGATCCCGTTCGCTATGGGTCCGGGTCCGGGTATCCGTGC  TGCTGAAATCCGTGCTTCTGCTAACCTGGCTGCTACCGGTCCGGGTCCGGGTGCT  GCTGAAATCCGTGCTTCTGCTAACCTGGCTGCTACCAAAATGGGTCCGGGTCCGG   GTACCCGTTTCGCTTCTGTTTACGCTTGGAACCGTAAACGTATCTCTGGTCCGGGT  CCGGGTGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCTCTGCACCGTGGTC  CGGGTCCGGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCTCTGCACCGTTC  T ", "cite_spans": [], "ref_spans": [{"start": 1, "end": 1314, "text": "ATGACCCCGCAGAACATCACCGACCTGTGCGCTGAATACCACAACACCCAGATC  CACACCCTGAACGACAAAATCTTCTCTTACACCGAATCTCTGGCTGGTAAACGTG  AAATGGCTATCATCACCTTCAAAAACGGTGCTACCTTCCAGGTTGAAGTTCCGGG  TTCTCAGCACATCGACTCTCAGAAAAAAGCTATCGAACGTATGAAAGACACCCT  GCGTATCGCTTACCTGACCGAAGCTAAAGTTGAAAAACTGTGCGTTTGGAACAA  CAAAACCCCGCACGCTATCGCTGCTATCTCTATGGCTAACGAAGCTGCTGCTAAA  TCTACCCAGGACCTGTTCCTGCCGTTCGGTCCGGGTCCGGGTTGGACCGCTGGTG  CTGCTGCTTACTACGGTCCGGGTCCGGGTTACCTGCAGCCGCGTACCTTCCTGCT  GGGTCCGGGTCCGGGTTACCAGCCGTACCGTGTTGTTGTTCTGGGTCCGGGTCCG  GGTTTCACCATCTCTGTTACCACCGAAATCGGTCCGGGTCCGGGTCAGATCATCA  CCACCGACAACACCTTCGGTCCGGGTCCGGGTCACTCTGCTTGGTCTCACCCGCA  GTTCGGTCCGGGTCCGGGTGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCT  CTGCACCGTGGTCCGGGTCCGGGTATCAACATCACCCGTTTCCAGACCCTGCTGG  CTCTGCACCGTTCTGGTCCGGGTCCGGGTCAGCCGTACCGTGTTGTTGTTCTGTCT  TTCGAACTGCTGCACGCTGGTCCGGGTCCGGGTCCGTACCGTGTTGTTGTTCTGTC  TTTCGAACTGCTGCACGCTCCGGGTCCGGGTCCGGGTGGTTGGACCTTCGGTGCT  GGTGCTGCTCTGCAGATCCCGTTCGCTGGTCCGGGTCCGGGTTGGACCTTCGGTG  CTGGTGCTGCTCTGCAGATCCCGTTCGCTATGGGTCCGGGTCCGGGTATCCGTGC  TGCTGAAATCCGTGCTTCTGCTAACCTGGCTGCTACCGGTCCGGGTCCGGGTGCT  GCTGAAATCCGTGCTTCTGCTAACCTGGCTGCTACCAAAATGGGTCCGGGTCCGG   GTACCCGTTTCGCTTCTGTTTACGCTTGGAACCGTAAACGTATCTCTGGTCCGGGT  CCGGGTGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCTCTGCACCGTGGTC  CGGGTCCGGGTATCAACATCACCCGTTTCCAGACCCTGCTGGCTCTGCACCGTTC  T", "ref_id": null}], "section": "annex"}]}